NCT03955393View on ClinicalTrials.gov

FAZA PET IMAGING IN DETECTING LYMPH NODE METASTASES IN RENAL CELL CARCINOMA PATIENTS

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

April 30, 2019

Study Completion Date

September 30, 2019

Conditions
Renal Cell Carcinoma (RCC)
Interventions
OTHER

18F-FAZA PET IMAGING TECHNIQUE IN DETECTING LYMPH NODE METASTASES IN RENAL CELL CARCINOMA PATIENTS

18F-FAZA is a highly selective PET radiotracer of hypoxia, which has been recently developed and tested in several studies (10-14). 18F-FAZA has been demonstrated to be a marker of hypoxia and pathological metabolic patterns which are common to all renal cancers.

Trial Locations (1)

20132

IRCCS San Raffaele, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER

NCT03955393 - FAZA PET IMAGING IN DETECTING LYMPH NODE METASTASES IN RENAL CELL CARCINOMA PATIENTS | Biotech Hunter | Biotech Hunter